Clinical Trial Design Showing Vaccine-Induced Clinical Efficacy
Time: 2:00 pm
day: Track B - Day 1 PM
Details:
- Discussing the current methods of testing immunogenicity
- Expanding the focus to testing clinical outcomes
- Demonstrating clinical benefits of neoantigens by controlled group clinical trial
